“Earlier Menopause, Older Brain?

Menopause is often discussed as a midlife transition: hot flushes, sleep disruption, mood changes, and then life moves on. But could the timing of menopause still be associated with how the brain ages decades later?

That is what researchers tested using two long-running aging cohorts: the Religious Orders Study and the Rush Memory and Aging Project. Participants were Catholic nuns or community-dwelling women without known dementia at enrollment and underwent annual clinical and cognitive assessments. Data availability differed by outcome: 2,603 contributed cognitive data, 774 had serial 3-Tesla MRI scans, and 1,287 contributed neuropathology data at autopsy. Follow-up extended to 18 years.

“White matter hyperintensities” are bright areas on MRI that are commonly used as markers of white-matter injury and cerebral small-vessel disease. Earlier spontaneous menopause was associated with faster accumulation — this image is an illustration, not an actual participant scan.

What the study found

1. The study combined several unusually deep sources of longitudinal data. The full cognitive cohort included 2,603 women, while 774 contributed serial 3-Tesla MRI data and 1,287 contributed autopsy neuropathology data. About two-thirds reported spontaneous menopause and one-third surgical menopause. Because the MRI subgroup was healthier and more cognitively intact than the full cohort, the investigators used weighting methods to reduce this selection imbalance in imaging analyses.

2. Earlier menopause was associated with slightly faster cognitive decline. In the full cohort, earlier menopause age was associated with faster decline in global cognition and episodic memory. Semantic and working memory showed similar directions but did not remain significant after false-discovery-rate correction; perceptual speed and visuospatial ability were not associated. The effect sizes were small.

3. Earlier menopause was associated with earlier clinical Alzheimer disease diagnosis. In the full cohort, the time-to-diagnosis model corresponded to roughly 2% faster Alzheimer onset per decade of earlier menopause. At the cohort's mean Alzheimer diagnosis age of 88.4 years, the authors translate this to about 1.8 fewer Alzheimer-free years for menopause occurring 10 years earlier. A separate surgical-menopause analysis showed a nominal 3% higher odds of Alzheimer diagnosis per year of earlier menopause, but subgroup findings were less robust after multiple-comparison correction and should not be treated as independently confirmed.

4. The standout MRI finding involved white-matter injury, not overall brain shrinkage. In women with spontaneous menopause, earlier menopause age was associated with substantially faster accumulation of white matter hyperintensity volume, and the association became more apparent with advancing age. The authors estimated that menopause occurring five years earlier would correspond to roughly 15% greater WMH volume accumulation over a decade, assuming the peak modeled difference in annual growth rate were sustained. This was the largest MRI effect in the study.

This WMH association was not detected in the surgical-menopause subgroup. The authors interpret that pattern as potentially related to the gradual hormonal trajectory of spontaneous menopause, but they also note alternative explanations, including the smaller surgical MRI subgroup, survivor selection and reduced variability after abrupt hormone withdrawal. The study does not establish the mechanism.

The practical idea behind the paper: menopause age is a midlife-identifiable marker that is known decades before late-life cognitive or MRI outcomes emerge. It is a risk marker, not a diagnosis.

5. Alzheimer neuropathology did not show the same pattern. Among women with autopsy data, menopause timing was not significantly associated with overall Alzheimer neuropathologic change after multiple-testing correction. A surgical-menopause subgroup signal was nominal before correction but did not survive FDR adjustment. The mismatch between clinical/MRI findings and Alzheimer pathology raises the possibility that non-amyloid pathways — including vascular injury — may matter, but this study does not establish a mechanism.

Now the part the headline can't fit

Most of the effects were small. The association with total brain-volume trajectory was statistically significant but had an effect size below the conventional threshold for a small association (f² = 0.013). The cognitive effects were also small. The clear exception was white matter hyperintensity accumulation after spontaneous menopause, which showed the largest structural effect in the study (f² ≈ 0.30).

Which came first? This is the deepest interpretive problem. Earlier menopause could contribute to later brain vulnerability, or it could partly mark accelerated systemic aging that affects both reproductive and brain aging. The authors note that surgically induced hormone withdrawal is less vulnerable to this particular reverse-causation problem, and some clinical associations were directionally stronger after surgical menopause. But surgical indications, procedure type and survivor selection introduce other biases, so causality remains unproven.

Menopause age was self-reported retrospectively. Recall error is possible. The authors note that nondifferential misclassification would generally be expected to bias associations toward the null, but that does not eliminate the possibility of measurement error.

Key parts of the reproductive story were missing. Pregnancy, parity, breastfeeding and oral-contraceptive history were not systematically available. “Surgical menopause” also combined different procedures, including bilateral oophorectomy and hysterectomy with ovarian conservation, which do not produce identical hormonal changes.

This was not a representative sample of all women. More than 92% were White, mean education was about 16 years, one cohort consisted of Catholic nuns, and mean age at enrollment was 78.3 years. Participants were free of known dementia at enrollment, and the MRI subgroup showed a healthy-volunteer effect, with higher baseline cognition and later Alzheimer diagnosis than the full cohort. Generalizability to more diverse populations is therefore uncertain.

This study cannot tell you whether menopausal hormone therapy protects the brain. Exploratory analyses found no significant interaction between MHT use and menopause-related brain-volume trajectories. But MHT was defined as systemic estrogen started within five years of menopause, only a minority of participants met that definition, and the analysis was not designed as a treatment trial. “No interaction detected” is not evidence that hormone therapy does or does not prevent dementia.

This post is a plain-language summary of published research and is not medical advice. The study is observational and cannot prove that menopause timing causes brain changes. Decisions about hormone therapy, memory concerns or cardiovascular risk should be made with your own clinician.

Source
Campagna MP, Schneider JA, Barnes LL, Arfanakis K, Dunietz GL, Bennett DA, Bove RM. Age at Menopause and Brain Atrophy Among Older Women. JAMA Network Open. 2026;9(8):e2630973. Published August 25, 2026. doi:10.1001/jamanetworkopen.2026.30973